Table 1.
Patient Demographics (n = 209)
| N (%) | |
|---|---|
| Age at treatment start, years | |
| Median (range) | 60.5 (22.0–86.4) |
| Gender | |
| Male | 124 (59.3) |
| Female | 85 (40.7) |
| M‐stage | |
| M0 | 40 (19.1) |
| M1A | 18 (8.6) |
| M1B | 34 (16.3) |
| M1C | 117 (56) |
| Prior systemic treatment | |
| Yes | 53 (25.3) |
| No | 156 (74.6) |
| Prior treatment, type | |
| None | 156 (74.6) |
| Chemotherapy | 9 (4.3) |
| PD1 | 18 (8.6) |
| Ipilimumab | 12 (5.7) |
| BRAF/MEK Inhibitors | 23 (11) |
| Other | 16 (7.6) |
| Prior treatment, number of lines | |
| Median (range) (N = 209) | 0 (0–7) |
| Last follow‐up status | |
| Dead | 58 (27.8) |
| Alive | 151 (72.2) |